Please provide your email address to receive an email when new articles are posted on . Megatrends happen in ophthalmology when new technology addresses existing patient needs and is met with ...
TECLens treated the first patient in a first-in-human trial assessing safety and efficacy of qCXL-based refractive correction ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
The human eye has a cornea covering its front that focuses light as it enters the eye. In cases of Salzmann’s Nodular Degeneration (SND), also known as nodular cornea degeneration, this usually clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results